Evidence map›Paper›PMID 37772456›Full record

ArticleJournal of biomedical materials research. Part A2024

Tissue formation and host remodeling of an elastomeric biodegradable scaffold in an ovine pulmonary leaflet replacement model.

Zurab Machaidze, Antonio D'Amore, Renata C C Freitas, Angelina J Joyce, Ahmed Bayoumi, Kimberly Rich, David W Brown, Elena Aikawa, William R Wagner, Bruno V Rego and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Zurab MachaidzeDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Antonio D'AmoreMcGowan Institute for Regenerative Medicine, Departments of Surgery and Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Renata C C FreitasDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Angelina J JoyceDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ahmed BayoumiDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kimberly RichDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
David W BrownDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Elena AikawaCenter for Excellence in Vascular Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
William R WagnerMcGowan Institute for Regenerative Medicine, Departments of Surgery and Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Bruno V RegoDepartment of Biological & Agricultural Engineering, Louisiana State University, Doran Building, Baton Rouge, Los Angeles, USA.
John E MayerDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-5849-2971
Boston Children's Hospital · USUniversity of Pittsburgh · USBrigham and Women's Hospital · USLouisiana State University · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Remodeling potential of the mitral valve following surgical repairR01HL119297 · NHLBI · UNIVERSITY OF TEXAS AT AUSTIN · PI GORMAN, JOSEPH H, SACKS, MICHAEL S · 2013 to 2017
$6.6M
Improving Mitral Compensation In Ischemic RegurgitationR01HL141917 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI AIKAWA, ELENA, BISCHOFF, JOYCE E. · 2018 to 2021
$5.6M
Mechanisms of In-Vivo Remodeling in Tissue Engineered Heart ValvesR01HL089750 · NHLBI · UNIVERSITY OF TEXAS AT AUSTIN · PI SACKS, MICHAEL S · 2007 to 2010
$3.1M
Macrophage-derived microcalcificaitonsR01HL136431 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, ELENA · 2017 to 2020
$2.7M
New driver of fibrosis and calcification in CAVDR01HL147095 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, ELENA · 2019 to 2022
$2.4M
Design and Simulation of Valvular Replacement BiomaterialsR01HL108330 · NHLBI · UNIVERSITY OF TEXAS AT AUSTIN · PI GORMAN, JOSEPH H, SACKS, MICHAEL S · 2012 to 2015
$2.3M
NCI NIH HHS P30 CA006516NHLBI NIH HHS R01 HL089750NHLBI NIH HHS R01 HL108330NHLBI NIH HHS R01 HL119297NHLBI NIH HHS R01 HL136431NHLBI NIH HHS R01 HL141917NHLBI NIH HHS R01 HL147095NIH HHS R01-HL108330NIH HHS R01-HL119297
6 · The paper itself

Abstract

In pursuit of a suitable scaffold material for cardiac valve tissue engineering applications, an acellular, electrospun, biodegradable polyester carbonate urethane urea (PECUU) scaffold was evaluated as a pulmonary valve leaflet replacement in vivo. In sheep (n = 8), a single pulmonary valve leaflet was replaced with a PECUU leaflet and followed for 1, 6, and 12 weeks. Implanted leaflet function was assessed in vivo by echocardiography. Explanted samples were studied for gross pathology, microscopic changes in the extracellular matrix, host cellular re-population, and immune responses, and for biomechanical properties. PECUU leaflets showed normal leaflet motion at implant, but decreased leaflet motion and dimensions at 6 weeks. The leaflets accumulated α-SMA and CD45 positive cells, with surfaces covered with endothelial cells (CD31+). New collagen formation occurred (Picrosirius Red). Accumulated tissue thickness correlated with the decrease in leaflet motion. The PECUU scaffolds had histologic evidence of scaffold degradation and an accumulation of pro-inflammatory/M1 and anti-inflammatory/M2 macrophages over time in vivo. The extent of inflammatory cell accumulation correlated with tissue formation and polymer degradation but was also associated with leaflet thickening and decreased leaflet motion. Future studies should explore pre-implant seeding of polymer scaffolds, more advanced polymer fabrication methods able to more closely approximate native tissue structure and function, and other techniques to control and balance the degradation of biomaterials and new tissue formation by modulation of the host immune response.

Indexed as

Heart Valve ProsthesisPulmonary ValveAnimalsBiocompatible MaterialsEndothelial CellsPolyestersPolymersSheepTissue EngineeringTissue ScaffoldsBiocompatible MaterialsPolyestersPolymersbiodegradable scaffoldheart valveinflammationPECUUtissue engineering

Identifiers

PMID37772456
PMCPMC11034854
OpenAlexW4387157664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.